UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer

ClinicalTrials.gov ID: NCT00064272

Public ClinicalTrials.gov record NCT00064272. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 18, 2026, 8:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Trial Of Encapsulized Ginger As A Treatment For Chemotherapy-Induced Nausea and Vomiting AKA IRB 2003-213

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: The herb ginger may help to reduce or prevent nausea and vomiting in patients receiving chemotherapy for cancer. PURPOSE: This randomized phase II trial is studying how well ginger works in reducing or preventing nausea and vomiting in patients who are receiving chemotherapy for cancer.

Study identification

NCT ID: NCT00064272
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Enrollment: 180 participants

Conditions and interventions

Conditions

Interventions

ginger extract Drug
placebo Other

Drug · Other

Eligibility (public fields only)

Age range: 18 Years to 120 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 2003 (Type not available)
Primary completion: May 2007 (Actual)
Completion: Not listed
Last update posted: Oct 21, 2016

Started 2003

United States locations

U.S. sites: 5
U.S. states: 3
U.S. cities: 4

Facility	City	State	ZIP	Site status
CCOP - Northern Indiana CR Consortium	South Bend	Indiana	46601	—
University of Michigan Cancer Center CCOP Research Base	Ann Arbor	Michigan	48109-0725	—
University of Michigan Comprehensive Cancer Center	Ann Arbor	Michigan	48109-0942	—
CCOP - Grand Rapids	Grand Rapids	Michigan	49503	—
MBCCOP - Our Lady of Mercy Cancer Center	The Bronx	New York	10466	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00064272, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 21, 2016 · Synced Oct 18, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00064272 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →